Immunocore Holdings plc filed a Form 8-K with the SEC on November 6, 2026, furnishing a press release announcing its financial results for the third quarter ended September 30, 2026, along with other recent corporate updates.
Protagonist Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the fiscal quarter and nine-month period ended September 30, 2026.
Green Plains Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 6, 2026, reporting third-quarter net income attributable to the company of $85,436 thousand on revenues of $495,990 thousand.
Global Mofy AI Limited filed a Form 6-K with the U.S. Securities and Exchange Commission on November 6, 2026, reporting the completion of a registered direct offering of 45,000,000 Class A ordinary shares.
CG Oncology, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting a net loss of $56.9 million for the third quarter and $196.1 million for the nine months ended September 30, 2026.
Assured Guaranty Ltd. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 6, 2026, covering the period ended September 30, 2026.
First Citizens BancShares, Inc. filed its Form 10-Q with the SEC on November 6, 2026, covering the quarterly period ended September 30, 2026, reporting net interest income of $1.699 billion for the third quarter and total assets of $241.182 billion.
XPEL, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting third-quarter total revenue of $137.8 million and net income attributable to stockholders of $16.3 million.
John Marshall Bancorp, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter net income of $7,541 thousand and total assets of $2.44 billion.
Forrester Research, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting a third-quarter net loss of $4.421 million and a year-to-date net loss of $10.993 million.